Medtronic Loses 5% in a Month: What's Next for MDT Investors? [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Broadly speaking, 2024 has not been smooth for investors in the Medical Products industry. Rising geopolitical pressure, primarily disruptions around the Red Sea, has increased freight costs and shipping lead times, spelling trouble for MDT and several of its direct competitors, like Abbott ABT and Boston Scientific BSX, thus putting pressure on their margins. Thankfully, there has been an improvement in investors' sentiment over the past month, with IMF's latest world economic outlook boasting about the global inflation rate declining steadily, from 6.8% in 2023 to 5.9% in 2024. While this has, to some extent, put an end to the downward spiral for most of the MedTech giants, Medtronic failed to keep pace with its peers' gradual northbound trend. Over the past month, shares of Medtronic have lost 5.2%, underperforming the industry's 0.8% decline and the S&P 500's 3.5% growth. While Boston Scientific and Abbott are gradually gaining momentum (with respective 1.2% and 1% improvement
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Rising Incidence of Urinary Tract Disorders Propels Ureteral Stents Market to Achieve USD 823.7 Million by 2031 | Transparency Market Research, Inc. [Yahoo! Finance]Yahoo! Finance
- United States Deep Brain Stimulation Market in Parkinson's Disease Poised for Remarkable Growth through 2029 [Yahoo! Finance]Yahoo! Finance
- Global Deep Brain Stimulation Market Forecasts to 2029: Key Trends Include Automated and Closed-Loop Deep Brain Stimulation, Rechargeable Devices with Longer Battery Life and Miniaturized DBS Devices [Yahoo! Finance]Yahoo! Finance
- Artisan Global Discovery Fund Trimmed Boston Scientific Corporation (BSX) for Valuation Discipline [Yahoo! Finance]Yahoo! Finance
- Defibrillator Research Report 2024: $12.24 Bn Market Insights, Competitive Landscape, Analysis & Forecasts 2023-2030 [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 4/24/24 - Miss
BSX
Sec Filings
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- 7/1/24 - Form 144
- BSX's page on the SEC website